Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

Dc Someone just said...bla bla bla..But did not elaborate...It can only be done on written approval by Radient..Not likely.Is AMDL a sub or division? In the 8-K it states it as a division..In the final agreement it is a subsidiary...This agreement is null and void..Radient could not enter into an agreement after March 1, 2013 and be legal..The agreement was drawn up in June 2013..lol Too funny and imo

Bottom line if it was legal..Radient is not obligated to agree as the agreement below states..imo

We filed a Current Report on Form 8-K on June 11, 2013 to disclose our entry into a 5-year license agreement between AMDL Diagnostics, Inc. (“ADI”), a division within our company, and Uni Pharma Co., Ltd. a Taipei Taiwan limited liability company (“UNI”)

http://www.sec.gov/Archives/edgar/data/838879/000121390013003193/f8k061113a1_radient.htm

This License Agreement (the “Agreement”), which shall be effective as of June 6th , 2013, is by and between Uni Pharma Co., Ltd., a Taipei, Taiwan limited liability company (“UNI”) and Radient Pharmaceuticals Corporation (including its subsidiary AMDL Diagnostics Inc.) a Delaware incorporated United States company (“RXPC”).

http://www.sec.gov/Archives/edgar/data/838879/000121390013003193/f8k061113a1ex10i_radient.htm



Gold Seeker Sunday, 03/01/15 02:43:12 PM
Re: None
Post # of 27805

"When UNI pharma licensed Onko Sure in 2013, they were given the right to sublicense the manufacture and sales of Onko sure. They apparently did so."


2.2

The Licenses are transferable only upon written approval by RXPC, although the Licenses are able to be sub-licensed by UNI, subject to the terms of this Agreement. RXPC will consider requests for transferability and will not unreasonably withhold approval of transfer provided such a transfer would not adversely affect the rights and obligations of RXPC.